8-KFiled Aug 19, 8:00 PM ET

ScanSource Announces MicroAge Acquisition; Reports FY2026 Q4 Results

$SCSC · SCANSOURCE, INC.

Research Summary

AI-generated summary of this SEC filing

Updated

ScanSource Announces MicroAge Acquisition; Reports FY2026 Q4 Results

What Happened
ScanSource, Inc. (SCSC) announced it entered a Stock Purchase Agreement to acquire all issued and outstanding capital stock of MicroAge, a technology provider serving managed cloud, data center, cybersecurity, IT and help‑desk markets. The purchase price is $220.5 million in cash at closing, with $3.0 million and $6.8 million placed in escrow for working‑capital/price adjustments and indemnification claims, respectively. The parties expect the Acquisition to close in September 2026, subject to customary conditions including Hart‑Scott‑Rodino clearance and certain third‑party consents. Separately, ScanSource filed a press release reporting its financial results for the fourth quarter and fiscal year ended June 30, 2026 and attached an earnings infographic; an updated investor presentation will be posted within about two weeks.

Key Details

  • Purchase price: $220.5 million cash payable at closing.
  • Escrows: $3.0M (post‑closing purchase price adjustments) and $6.8M (indemnification).
  • Expected close: September 2026, subject to HSR waiting period expiration/termination and required consents.
  • Target business: MicroAge — managed cloud, data center, cybersecurity, IT services and help‑desk solutions.
  • ScanSource also issued Q4 and FY2026 results (press release and infographic filed as Exhibits 99.1/99.2); investor deck to follow.

Why It Matters
This transaction expands ScanSource’s capabilities into managed services and cybersecurity areas via MicroAge’s technology and services footprint. The $220.5M cash deal and escrow structure highlight potential post‑closing adjustments and indemnity risk protections; closing is still subject to regulatory and third‑party approvals. Investors should review the company’s Q4/FY2026 press release and forthcoming investor presentation for financial impacts and monitor regulatory clearance and any purchase‑price adjustments disclosed after closing. The filing also includes standard forward‑looking statements and risk disclosures.